Quick Takeaways
- Capital World Investors filed SCHEDULE 13G for Ionis Pharmaceuticals, Inc. Common Stock (IONS).
- Disclosed ownership: 7.3%.
- Date of event: 31 Dec 2024.
Capital World Investors - 31 Dec 2024 SCHEDULE 13G Report for Ionis Pharmaceuticals, Inc. Common Stock (IONS)
- Filing Manager
- Capital World Investors
- Reporting Manager
- Capital World Investors
- Symbol
- IONS
- Shares outstanding
- 157,060,452 shares
- Disclosed Ownership
- 11,465,413 shares
- Ownership
- 7.3%
- Form type
- SCHEDULE 13G
- Filing time
- 13 Feb 2025, 16:53:14 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 07 Jan 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Capital World Investors disclosed 7.3% ownership in Ionis Pharmaceuticals, Inc. Common Stock (IONS) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Feb 2025, 16:53.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Capital World Investors | 7.3% | 11,465,413 | 11,465,413 | 0 | Jae Won Chung | Vice President and Senior Counsel II, Capital Research and Management Company |